Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?

Kidney involvement, termed lupus nephritis (LN), develops in 35–60% of patients with systemic lupus erythematosus, often early during the disease course. When not treated promptly and efficiently, LN may lead to rapid and severe loss of kidney function, being the reason why it is considered one of t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archivum Immunologiae et Therapiae Experimentalis 2022, Vol.70 (1), p.8-8, Article 8
Hauptverfasser:	Parodis, Ioannis, Tamirou, Farah, Houssiau, Frédéric A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Autoimmunity Biomedical and Life Sciences Biomedicine Biopsy Decision making Drug therapy End-stage renal disease Humans Immunology Kidney Kidney biopsy Kidney diseases Kidney disorders Kidney Failure, Chronic Lupus Lupus Erythematosus, Systemic Lupus nephritis Lupus Nephritis - diagnosis Lupus Nephritis - drug therapy Medical prognosis Nephritis Pharmacology/Toxicology Prognosis Renal function Retrospective Studies Review Systemic lupus erythematosus Treat-to-target
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!